 local control surviv cooper osteosarcoma studi group studi german societi pediatr oncolog vienna bone tumor registri use aggress chemotherapi dramat increas cure rate osteosarcoma author investig author knowledg chemotherapi osteosarcoma differenti efficaci agent pronounc schedul depend rel rout independ effici author abl prognost signific tumor respons preoper chemotherapi preoper chemotherapi limb-salvag surgeri patient today use aggress thorac surgeri case primari secondari pulmonari metastas author effort metastasis-fre surviv rate chemotherapi seri studi success chemotherapy-rel acut toxic consider aggress treatment manifest late toxic follow-up time futur trial explor minimum indispens amount toxic treatment compar result attain